Quality of oral anticoagulation treatment in real-life practice and factors associated with optimal therapeutic response in elderly patients

被引:0
|
作者
Tiratera, F. [1 ]
Lanti, F. [2 ]
Placido, A. [1 ]
Magrini, A. [3 ]
Pietroiusti, A. [3 ]
机构
[1] Osped Santo Spirito, UOC Med Interna ASL RME, Rome, Italy
[2] Osped Nuovo Regina Margherita ASL RMA, Rome, Italy
[3] Univ TorVergata, Dipartimento Biopatol Med Occupazionale, Rome, Italy
关键词
Elderly patients; Oral anticoagulation therapy; International normalized ratio; Atrial fibrillation;
D O I
暂无
中图分类号
学科分类号
摘要
Introduction. Oral anticoagulation therapy (OAT) is recommended in several cardiovascular disorders and is increasingly used in elderly patients. Obtaining a stable value of International Normalized Ratio (INR) within the target levels may however represent a difficult goal, in this population. Indeed, there is suggestion that out of range INR values are frequently seen in clinical practice. This fact may be associated with serious adverse events such as bleeding and thromboembolic disorders, which may be often fatal in elderly people. Aim of the present study was to evaluate the factors associated with an increased risk of out of range INR levels in this subgroup of patients. Methods. Consecutive patients admitted to the Emergency Department of two Italian Institutions were analyzed within two hours of their admission. Only patients 70 years or older were eligible for the study. Results. 242 patients were enrolled, 151 of whom (62.4%) with abnormal values. When comparing the characteristics of those within or outside the normal range, it appeared that the former had a higher educational level (27% vs 5%) and more frequently a duration of treatment longer than 5 years (62% vs 27%): OR=7.36; 95% C.I. 3.02-17.95; p < 0.0001, and OR=4.29; 95% C.I. 2.46-7.47; p < 0.0001, respectively. Discussion. The majority of patients in this sample of elderly patients seem unable to maintain optimal INR values. The risk seems higher in patients with a low level of education and with less than 5 year OAT.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 50 条
  • [31] Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real-life practice: the resoswitch study
    Dabouz, F.
    Khemis, A.
    Lahfa, M.
    Maccari, F.
    Chaby, G.
    Beneton, N.
    Boye, T.
    Esteve, E.
    Mahe, E.
    Begon, E.
    Pauwels, C.
    Bernard, P.
    Reguiai, Z.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 16 - 16
  • [32] Use of Human Immunoglobulins in Secondary Immunodeficiencies Associated with Hematological Malignancy in Real-Life Practice: Which Patients, Which Treatment?
    Benbrahim, Omar
    Grosbois, Bernard
    Viallard, Jean-Francois
    Choquet, Sylvain
    Royer, Bruno
    Dreyfus, Brigitte
    Fleck, Emmanuel
    Carreiro, Miguel
    Clerson, Pierre
    Crave, Jean Charles
    Delain, Jeanchristophe
    Levy, Vincent
    BLOOD, 2014, 124 (21)
  • [33] Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real-life practice: The Resoswitch study
    Dabouz, Fadia
    Khemis, Abdallah
    Barbe, Christine
    Lahfa, Mourad
    Maccari, Francois
    Chaby, Guillaume
    Beneton, Nathalie
    Boye, Thierry
    Esteve, Eric
    Mahe, Emmanuel
    Begon, Edouard
    Pauwels, Christine
    Bernard, Philippe
    Taieb, Charles
    Reguiai, Ziad
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [34] Oral health-related quality of life and associated factors in Southern Brazilian elderly
    Silva, Alexandre E. R.
    Demarco, Flavio F.
    Feldens, Carlos A.
    GERODONTOLOGY, 2015, 32 (01) : 35 - 45
  • [35] Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin
    Vitfell-Rasmussen, Joanna
    Krarup-Hansen, Anders
    Vaage-Nilsen, Merete
    Kumler, Thomas
    Zerahn, Bo
    ACTA ONCOLOGICA, 2022, 61 (07) : 801 - 808
  • [36] Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients
    Lundqvist, Christofer
    Beiske, Antonie Giaever
    Reiertsen, Ola
    Kristiansen, Ivar Sonbo
    JOURNAL OF NEUROLOGY, 2014, 261 (12) : 2438 - 2445
  • [37] Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients
    Christofer Lundqvist
    Antonie Giæver Beiske
    Ola Reiertsen
    Ivar Sønbø Kristiansen
    Journal of Neurology, 2014, 261 : 2438 - 2445
  • [38] Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results
    Uslu, Sadettin
    Gulle, Semih
    Urak, Ozkan
    Sen, Gercek
    Dalkilic, Ediz
    Senel, Soner
    Akar, Servet
    Inanc, Nevsun
    Cefle, Ayse
    Avsar, Aydan Koken
    Yolbas, Servet
    Yilmaz, Sema
    Gunduz, Ozguel Soysal
    Sari, Ismail
    Birlik, Merih
    Akkoc, Nurullah
    Onen, Fatos
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (02) : 232 - 241
  • [39] Treatment delivery and outcomes in elderly myeloma patients at The Royal Bournemouth hospital; Real-life data
    Smith, Alistair
    Hall, Rachel
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 124 - 124
  • [40] RESULTS OF "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Latagliata, R.
    Stagno, F.
    Annunziata, M.
    Iurlo, A.
    Scappini, B.
    Guarini, A.
    Giglio, G.
    Fava, C.
    Sora, F.
    Capodanno, I.
    Crugnola, M.
    Crescenzi, S. Leonetti
    Barsotti, S.
    Feo, C.
    Breccia, M.
    Vigneri, P.
    Cambrin, G. Rege
    Gozzini, A.
    Alimena, G.
    HAEMATOLOGICA, 2014, 99 : 604 - 604